Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRDJZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,338
Award facts
- Contract value 100% obligated
- $52,338.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,338.34 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a monoclonal antibody used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions, making this a significant pharmaceutical supply contract supporting military and defense healthcare requirements.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen has demonstrated consistent capability to fulfill competitive federal procurement requirements across an expansive portfolio of pharmaceutical products and medical supplies. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FRDJZ?
SPE2DB25FRDJZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FRDJZ worth?
The government has obligated $52,338 on SPE2DB25FRDJZ.
Is contract SPE2DB25FRDJZ an order under another contract?
Yes. SPE2DB25FRDJZ is a delivery order under SPE2DB25D3008, an indefinite delivery contract.
Was contract SPE2DB25FRDJZ competed?
The extent of competition for SPE2DB25FRDJZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award